OPPORTUNITY RADAR SCREENER COMPARE ANY 2 STOCKS

EARNINGS CALL ARCHIVE 4 CALLS ON FILE

MIRM — Mirum Pharmaceuticals, Inc.

NASDAQ

FULL STOCK PAGE →

Q2 2026 Earnings Call Summary

AUG 5, 2026

REVENUE

$176.2M +10.2%

NET MARGIN

-38.1% +456.1 PTS

EPS

-$1.06 +92.1%

FREE CASH FLOW

-$273.7M -19.3%

No summary has been written for this call yet.